LoveYourself Inc, Mandaluyong City, Philippines.
Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
BMJ Open. 2023 Sep 5;13(9):e072252. doi: 10.1136/bmjopen-2023-072252.
We aimed to describe the gender-affirming hormonal therapy (GAHT) intake behaviour and regimen and the factors associated with the use of hormones inconsistent with reference GAHT regimen among transgender people in the Philippines.
Cross-sectional study.
Transgender community clinic in Metro Manila, Philippines from March 2017 to December 2019.
Gender-affirming care-seeking individuals of at least 18 years old, who self-identified as transgender or non-binary, and who self-reported current or previous use of GAHT at baseline consult.
Reported drugs and/or administration routes not congruent with the World Professional Association for Transgender Health Standard of Care eighth edition were classified as hormone use outside the reference regimen.
253 transgender people reported current or previous intake of GAHT. Many trans women and transfeminine people (TWTFP; 58.9%, 86/146) reported using oral contraceptive pills (OCPs), whereas most trans men (TM; 73.8%, 79/107) reported injecting testosterone esters. Furthermore, 59.7% (151/253) used hormones outside the reference regimen, widely using OCP and anabolic steroids among TWTFP and TM, respectively. TWTFP (crude prevalence ratio, PR, 3.52; 95% CI 2.35 to 5.49) and those who take unprescribed GAHT (crude PR 2.37; 95% CI 1.08 to 6.68) were more likely to use hormones outside the reference regimen than TM and taking healthcare provider-prescribed GAHT, respectively. On adjusting for covariates, the prevalence of using hormones outside the reference regimen was approximately three times higher (adjusted PR 3.22; 95% CI 2.09 to 5.12) among TWTFP than TM.
Trans people act on their high unmet gender-affirming care needs by taking unprescribed GAHT, many outside the reference regimen. Structural changes in the health system are warranted, including strengthened community-based self-administration practices.
本研究旨在描述菲律宾跨性别者的性别肯定激素治疗(GAHT)摄入行为和方案,并分析与参考 GAHT 方案不符的激素使用相关因素。
横断面研究。
菲律宾马尼拉都会区的跨性别者社区诊所,时间为 2017 年 3 月至 2019 年 12 月。
至少 18 岁的寻求性别肯定护理的个体,自我认同为跨性别者或非二元性别者,且在基线咨询时报告当前或既往使用过 GAHT。
报告的药物和/或给药途径与世界专业协会治疗跨性别者健康第八版标准不相符的情况被归类为参考方案之外的激素使用。
253 名跨性别者报告了当前或既往摄入 GAHT。许多跨性别女性和跨性别女性气质者(TWTFP;58.9%,86/146)报告使用口服避孕药(OCP),而大多数跨性别男性(TM;73.8%,79/107)报告注射睾酮酯。此外,59.7%(151/253)的人使用了参考方案之外的激素,TWTFP 和 TM 分别广泛使用 OCP 和合成代谢类固醇。TWTFP(未经调整的患病率比,PR,3.52;95%置信区间 2.35 至 5.49)和使用未经处方 GAHT 的人(未经调整的 PR 2.37;95%置信区间 1.08 至 6.68)比 TM 和接受医疗保健提供者开具的 GAHT 的人更有可能使用参考方案之外的激素。在调整了协变量后,TWTFP 使用参考方案之外的激素的患病率大约高出三倍(调整后的 PR 3.22;95%置信区间 2.09 至 5.12)。
跨性别者通过服用未经处方的 GAHT 来满足其未满足的高度性别肯定护理需求,其中许多人使用的是参考方案之外的药物。需要对卫生系统进行结构性改革,包括加强社区为基础的自我管理实践。